CRISPR Therapeutics AG (CRSP)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

43.85

0.23%

After-hours Dec 13, 2024, 07:08 PM EST

CRISPR Therapeutics AG Forcast

Stock Price Forecast

The 17 analysts with 12-month price forecasts for CRSP stock have an median target of 84, with a low estimate of 48 and a high estimate of 105. The median target predicts an increase of 92.00% from the current stock price of 43.75.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$48	$77.07	$84	$105
Change	9.71%	76.16%	92.00%	140.00%

AI Analyst Report

Chardan Capital maintains a Buy rating on CRISPR T... Unlock content with Pro Subscription

Updated Dec 10, 2024

Rating	May 24	Jun 24	Aug 24	Oct 24	Nov 24	Dec 24
Strong Buy	0	0	0	0	0	0
Buy	4	3	3	0	1	1
Hold	4	1	4	1	2	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	4	7	1	3	1

Financial Forecast this Year

Revenue This Year

46.73M

from 370.00M

-87.4%

from 370.00M

Revenue Next Year

261.88M

from 46.73M

460.4%

from 46.73M

EPS This Year

-5.6

from -1.94

-188.7%

from -1.94

EPS Next Year

-5.65

from -5.6

-0.9%

from -5.6